Press Releases

Date Title and Summary
Toggle Summary Accuray Unveils VOLO™ Ultra, the Latest Innovation for the Radixact® System, at ASTRO 2021
Showcases Multiple Forward-Looking Radiotherapy Solutions Designed to Enhance the Treatment Experience for Medical Care Teams and Their Patients SUNNYVALE, Calif. , Oct. 19, 2021 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today the company is showcasing its new VOLO™ Ultra for
Toggle Summary Accuray will showcase its CyberKnife® and TomoTherapy® Systems at CHINA-HOSPEQ 2013
SUNNYVALE, Calif. , Aug. 16, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today its participation in the 22 nd China International Medical Instruments and Equipment Exhibition and Seminar ( CHINA -HOSPEQ), taking place from Friday, August 16 to Sunday, August 18, 2013 .
Toggle Summary Accuray Wins Innovations in Healthcare(SM) ABBY Award
Award from Adaptive Business Leaders (ABL) Organization Recognizes Companies with Transformative Advances in Healthcare SUNNYVALE, Calif., April 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the company won the
Toggle Summary Accuray's CFO to Present at B. Riley & Company Ninth Annual Investor Conference
SUNNYVALE, Calif., March 27 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its senior vice president and chief financial officer, Robert E. McNamara, is scheduled to present at the B.
Toggle Summary Accuray's CyberKnife and TomoTherapy Systems Highlighted at World Conference on Lung Cancer
Research points to ability of these technologies to extend treatment options for a wide range of lung cancer patients SUNNYVALE, Calif., July 7, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced new clinical data highlighting the
Toggle Summary Accuray's CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
SUNNYVALE, Calif., March 12 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company received the 2008 North American Medical Devices Product of the Year award, from global growth consulting company Frost &
Toggle Summary Accuray's CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting
40 Presentations Highlight CyberKnife Radiosurgery for Intracranial and Extracranial Indications SUNNYVALE, Calif., Oct 29, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that 40 accepted abstracts highlighting the
Toggle Summary Accuray's CyberKnife VSI System Named Best New Radiology Device
Receives 2010 Minnie Award from Leading Medical Imaging Site, AuntMinnie.com SUNNYVALE, Calif., Nov. 29, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company's CyberKnife(R) VSI(TM) System received the
Toggle Summary Accuray's CyberKnife(R) G4 System Receives Shonin Approval
Latest Advances in CyberKnife Radiosurgery Now Available in Japan SUNNYVALE, Calif., Aug 03, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today it received Shonin approval from the Japanese Ministry of Health, Labor and
Toggle Summary Accuray's Euan Thomson Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Recipient in Northern California
Award Recognizes Entrepreneurial Excellence in Health and Life Sciences Category SUNNYVALE, Calif ., June 17 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Euan Thomson , Ph.D., the company's president and CEO,

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.